A novel dual-doping strategy is developed by incorporating serine into the SnO 2 ETL and o-TB-GDY into the Spiro-OMeTAD HTL, respectively.
Share your take
Add a clinician perspective alongside expert commentary.
Wang et al. (Thu,) studied this question.